Artificial Intelligence in Coronary Artery Disease: From Detection to Precision Management
Authors: Garg, Keshav; Bruich, Landon; Enemark, Luke J; Sawalha, Khalid; Rana, Aakash; Agrawal, Ankit; Spraggins, Robert F 2nd; Khalaila, Osama; Shehadeh, Mohanad; Alhwarat, Buthainah; Johnson, Carsten; Guha, Avirup; Zhang, Yiye; Pontone, Gianluca; Dani, Sourbha S; Chindambaram, Vignesh; Baskaran, Lohendran; Tayal, Bhupendar; Al'Aref, Subhi J
Source journal: Methodist DeBakey cardiovascular journal (2026-01-01)
DOI: 10.14797/mdcvj.1917
Abstract
Coronary artery disease (CAD) remains the leading cause of death worldwide, yet the landscape is rapidly evolving as artificial intelligence (AI) is increasingly applied to its detection, diagnosis, and management. This review surveys the expanding role of AI across the full spectrum of CAD care. In screening, deep-learning electrocardiography and electronic health record-based digital markers enable earlier identification of clinically significant disease. In noninvasive imaging, AI-driven coronary computed tomography angiography automates calcium scoring, derives fractional flow reserve without invasive wires, and quantifies high-risk plaque features that predict incident adverse events. Within the cardiac catheterization laboratory, angiography-derived physiologic assessment and AI-guided intravascular imaging segmentation support real-time procedural decision-making. Beyond diagnosis, machine-learning models integrating multimodality imaging data improve risk stratification over conventional clinical scores, while pharmacogenomic algorithms and wearable-based digital rehabilitation platforms enable patient-centric secondary prevention. Despite this progress, significant challenges persist, including limited evidence from randomized trials, algorithmic bias in underrepresented populations, regulatory uncertainty surrounding software-as-a-medical-device frameworks, and the risk of clinician de-skilling. AI has the potential to act as a collaborative tool that augments-rather than replaces-physician judgment. Future directions include foundation models, multiomics integration, agentic AI workflows, and equity-centered deployment strategies to ensure that AI-driven advances benefit all individuals with CAD.
Related topics
Related open access articles
- IMMUNE RELATED DISEASES AND THEIR RELATIONSHIP WITH THE GENETIC VARIABILITY WITHIN THE ADENOSINE DEAMINASE GENE
- ENTEROPARASITES, RESPIRATORY ALLERGY AND OTHER SIGNS AND SYMPTOMS IN CHILDS AND YOUTH POPULATION OF RECÔNCAVO OF BAHIA – BRAZIL
- Proctocolitis in a child treated with oral immunotherapy for cow’s milk allergy
- Non-ionic Contrast Allergy Manifesting as Stevens Johnson Syndrome and Erythema Multiforme
- Can dietary intervention be an auxiliary therapy for Rheumatoid Arthritis?
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.